找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Identification of Biomarkers, New Treatments, and Vaccines for COVID-19; Paul C. Guest Book 2021 The Editor(s) (if applicable) and The Aut

[復(fù)制鏈接]
樓主: Nixon
11#
發(fā)表于 2025-3-23 12:24:09 | 只看該作者
Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reason explanations for this disparity are not clear. Thus, we attempted to identify rational explanations about age-related differences as reported in different studies. Given the incomplete data on SARS-CoV-2, some information has been gathered from other studies of earlier coronavirus or influenza outb
12#
發(fā)表于 2025-3-23 14:35:31 | 只看該作者
13#
發(fā)表于 2025-3-23 20:58:38 | 只看該作者
14#
發(fā)表于 2025-3-23 22:44:19 | 只看該作者
15#
發(fā)表于 2025-3-24 05:10:07 | 只看該作者
16#
發(fā)表于 2025-3-24 08:14:43 | 只看該作者
How Do We Manage Breastfeeding During the COVID-19 Pandemic? including sexual and reproductive health, publishing in all of these areas has increased lately. One aspect that requires basing on scientific evidence is breastfeeding. There are some controversies in the literature on the breastfeeding management in confirmed COVID-19 mothers. Breast milk is exce
17#
發(fā)表于 2025-3-24 12:21:45 | 只看該作者
18#
發(fā)表于 2025-3-24 16:42:15 | 只看該作者
Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review study the effect of ozone therapy on COVID-19 patients and the available supporting evidence. Electronic databases including MEDLINE (via PubMed), EMBASE, Cochrane Library (CENTRAL), and TRIP, clinical trial registries, and preprint sources were searched for published evidence-based articles. In ad
19#
發(fā)表于 2025-3-24 22:10:53 | 只看該作者
20#
發(fā)表于 2025-3-25 02:44:43 | 只看該作者
Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19)n the oral and nasal cavities, agents that act on these two areas have the potential for large therapeutic and prophylactic benefit. A literature review was conducted to elucidate the possible agents useful in treatment of SARS-CoV-2. These agents were evaluated for their current applications, adver
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-27 18:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
黄梅县| 巧家县| 云霄县| 哈巴河县| 叶城县| 肃宁县| 公主岭市| 商丘市| 武汉市| 屏南县| 桦南县| 革吉县| 福安市| 阳西县| 陈巴尔虎旗| 虹口区| 图木舒克市| 牡丹江市| 教育| 岗巴县| 奉贤区| 凌云县| 鄂尔多斯市| 广东省| 文水县| 普安县| 尚义县| 惠州市| 名山县| 禄丰县| 湘潭市| 都江堰市| 西乌珠穆沁旗| 禹城市| 德江县| 屯昌县| 娄底市| 丁青县| 河东区| 安顺市| 鹤山市|